Commodore Capital Lp Insider Trades

Insider Trading History

Track insider trading activity for Commodore Capital Lp. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vera Therapeutics
Vera Therapeutics VERA
10% owner
Holding Value $138M 4,400,000 shares
Last Trade
Jan 10, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$18.9M 1,050,000 shares
$18.00
$31.27
Vistagen Therapeutics
Vistagen Therapeutics VTGN
10% owner
Holding Value $1.56M 2,788,620 shares
Last Trade
Oct 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.6M 3,084,324 shares
$3.43
$0.56
Vistagen Therapeutics
Vistagen Therapeutics VTGN
10% owner
Holding Value $882k 1,575,000 shares
Last Trade
Aug 07, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.1M 775,756 shares
$13.05
$0.56
Vera Therapeutics
Vera Therapeutics VERA
10% owner
Holding Value $170M 5,450,000 shares
Last Trade
Jun 20, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.8M 448,217 shares
$15.17
$31.27
Enliven Therapeutics
Enliven Therapeutics ELVN
10% owner
Holding Value $25.9M 718,749 shares
Last Trade
Feb 23, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15.7k 621 shares
$25.28
$36.03
Imara
Imara IMRA
10% owner
Holding Value $12.5M 718,749 shares
Last Trade
Feb 23, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.92k 621 shares
$6.32
$17.45
Enliven Therapeutics
Enliven Therapeutics ELVN
10% owner
Holding Value $52.2M 1,448,640 shares
Last Trade
Feb 23, 2023 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$18.5M 729,891 shares
$25.28
$36.03
Imara
Imara IMRA
10% owner
Holding Value $25.3M 1,448,640 shares
Last Trade
Feb 23, 2023 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$4.61M 729,891 shares
$6.32
$17.45
Enliven Therapeutics
Enliven Therapeutics ELVN
10% owner
Holding Value $103M 2,872,513 shares
Last Trade
Feb 22, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$514k 23,565 shares
$21.80
$36.03
Imara
Imara IMRA
10% owner
Holding Value $50.1M 2,872,513 shares
Last Trade
Feb 22, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$120k 23,565 shares
$5.11
$17.45
Imara
Imara IMRA
10% owner
Holding Value $49.7M 2,848,948 shares
Last Trade
Feb 21, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$43k 8,194 shares
$5.25
$17.45
Enliven Therapeutics
Enliven Therapeutics ELVN
10% owner
Holding Value $103M 2,848,948 shares
Last Trade
Feb 21, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$175k 8,194 shares
$21.32
$36.03
Satsuma Pharmaceuticals
Satsuma Pharmaceuticals STSA
Director
Holding Value $507k 461,286 shares
Last Trade
Nov 14, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.31M 3,250,000 shares
$0.71
$1.10
Satsuma Pharmaceuticals
Satsuma Pharmaceuticals STSA
10% owner
Holding Value $4.08M 3,711,286 shares
Last Trade
Nov 24, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15.8k 2,922 shares
$5.42
$1.10
Satsuma Pharmaceuticals
Satsuma Pharmaceuticals STSA
10% owner
Holding Value $4.08M 3,708,364 shares
Last Trade
Nov 22, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$54.8k 9,979 shares
$5.49
$1.10
Satsuma Pharmaceuticals
Satsuma Pharmaceuticals STSA
10% owner
Holding Value $4.07M 3,698,385 shares
Last Trade
Nov 19, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.5k 3,225 shares
$5.44
$1.10
Satsuma Pharmaceuticals
Satsuma Pharmaceuticals STSA
10% owner
Holding Value $4.06M 3,695,160 shares
Last Trade
Nov 11, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$48k 7,941 shares
$6.05
$1.10
Satsuma Pharmaceuticals
Satsuma Pharmaceuticals STSA
10% owner
Holding Value $4.06M 3,687,219 shares
Last Trade
Nov 10, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$56.3k 9,622 shares
$5.85
$1.10
Satsuma Pharmaceuticals
Satsuma Pharmaceuticals STSA
10% owner
Holding Value $4.05M 3,677,597 shares
Last Trade
Nov 08, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.35k 560 shares
$5.99
$1.10
Satsuma Pharmaceuticals
Satsuma Pharmaceuticals STSA
10% owner
Holding Value $4.04M 3,677,037 shares
Last Trade
Nov 05, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$46.4k 7,800 shares
$5.95
$1.10

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up